Fig. 2From: HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancerAssociation of CK+ and CK− CTCs and tdEVs with the clinical outcome of metastatic breast cancer patients. KM curves for OS dichotomizing patients based on their automated CK+ CTCs (a) and tdEVs (b) and their CK− CTCs (c) and tdEVs (d)Back to article page